Catalysts
PRODUCTS
-
KRYTAR specializes in the design and manufacturing of ultra-broadband microwave components and test equipment for both commercial and military applications.
-
A transformative cell line development workflow with automated clone screening and optional monoclonality assurance on day 0*
The ClonePix® 2 Mammalian Colony Picker is a complete solution for the automated screening and objective selection of high-value clones across diverse cell types.
The ClonePix® 2 Mammalian Colony Picker is a fully automated system for selecting high-value clones used in antibody discovery and cell line development. Screen more clones in less time with monoclonal verification on day zero, then screen and identify for highest producers in weeks, not months.
-
Say goodbye to paper and manual spreadsheets and hello to maximum efficiency, productivity, and visibility! Plex MES is the only single-instance, multi-tenant cloud-based SaaS production platform that operates at scale. This allows for a common production ecosystem that supports a real-time, single source of data. It can tie production and inventory to quality with end-to-end, detailed traceability. With Plex, you can connect people and systems, automate processes, track data from end to end, and capture and analyze information like never before.
-
PHCbi brand's 12.7 cu.ft (360L) ultra-low temperature freezer features a dual cooling system to offer our highest level of sample protection through the use of two independent refrigeration systems. TwinGuard Series freezers are ideal for safe, long term storage of your most high valued products, such as stem cells, embryos, cell lines, rare specimens, and other biological materials.
-
GO BEYOND with the SCIEX 7500 system, high performance triple quadrupole LC-MS/MS mass spectrometer
Enter a new era of sensitivity and LC-MS/MS innovation with the SCIEX 7500 system. GO BEYOND current limits of sensitivity, productivity targets, ruggedness and robustness challenges. Pioneer new discoveries with this innovation.
WHITE PAPERS AND CASE STUDIES
-
Proactive WWTP Design And Innovation Improves Health Of Chesapeake Bay Watershed
Read about the $568 million, decade-long upgrade of a Water Pollution Control Plant that would expand the plant’s capacity from 30 mgd to 40 mgd while also reducing nitrogen and phosphorous to the limit of technology.
-
Authentic Engagement: Reaching Underserved Lupus Patients
By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.
-
How Waterloo Harnessed Qatium's Digital Platform
Read about the City of Waterloo, that needed an intuitive, low-cost tool to empower operators without requiring specialized technical expertise.
-
Case Study: Secure Electronic Warfare Systems
The most advanced microelectronics technology is critical for the aerospace and defense industry. For this customer, that meant state-of-the-art heterogeneous processing.
-
Sulzer Submersible Aerator Mixer Improves Wastewater Treatment In A Cardboard Mill
With the increase of a WWTP's capacity, the oxygenation of its basins had become insufficient. Learn about the upgrade of its aeration performance of the existing installation with minimal capital expenditure.
-
Global Biotech Improves Clinical Trial Patient Recruitment With Digital Matching
A global biotech initiated a phase III study for severe allergic asthma. Study protocol originally accounted for enrolling 222 patients across nine UK-based investigator sites. After deploying traditional recruitment methods, the sponsor only managed to randomize 20% of the target patient population in 11 months. By partnering with a solution provider they were able to get patient recruitment back on track and meet enrollment targets faster, which would not have been possible with a traditional recruitment approach.
-
Tank Terminal Wastewater Treatment
In this case study, explore the results of Aquacycl's installation of a pilot-scale BETT system to treat a side-stream of wastewater from a tank terminal operator's facility.
-
Global CRO Streamlines Study Startup By Centralizing IRB Review
See how PRA Health Sciences was able to convert to a central IRB to improve the overall study startup processes and timelines.
-
Comparative Analysis Of Batch And Continuous Processes
Explore a comparative analysis that showcases the superior performance of continuous processing over traditional batch methods, highlighting key improvements in efficiency and environmental impact.
-
Difco TC Yeastolate Ultra-Filtered (TCY UF) In Scale-Up Optimization
Explore how Difco™ TC Yeastolate ultra-filtered (TCY UF) enabled over 100% improvement in titer for CHO cell culture through feed optimization and bioreactor scalability in a real-world application.
-
No More Odors Here In Bakersfield California: Replacing Calcium Nitrate With SulFeLox®
Faced with increasing costs for controlling hydrogen sulfide in its wastewater collection system, the City of Bakersfield, California commissioned an evaluation of its program in 2019.
-
Meet The Demand: Doubling Capacity At Two 503(b) Manufacturing Sites
503B compounders require special attention to maintain cGMP and regulation compliance. Examine the process for designing and managing new facilities for sterile and parenteral injectable manufacturing.
NEWS
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Stoichiometric Crystal Shows Promise In Quantum Memory7/7/2025
For over two decades, physicists have been working toward implementing quantum light storage—also known as quantum memory—in various matter systems.
-
Plants Don't Just Feel The Heat – They Decode It Through A Molecular Network6/13/2025
In a new framework that could reshape how we engineer crops for a warming world, scientists have revealed that plants don't rely on a single "thermometer" to sense temperature.
-
The Fire That Powers The Universe: Harnessing Inertial Fusion Energy12/1/2024
It was a laser shot for the ages. By achieving fusion ignition on December 5, 2022, Lawrence Livermore National Laboratory (LLNL) proved that recreating the “fire” that fuels the sun and the stars inside a laboratory on Earth was indeed scientifically possible.
-
Bühler Opens Application Center For Local Grains In Nigeria Together With Flour Mills Of Nigeria7/11/2024
Bühler, in collaboration with Flour Mills of Nigeria Plc, has opened a grains application center in Nigeria dedicated to processing local and ancient grains.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.